These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6354433)

  • 61. Co-amplification of double minute chromosomes, multiple drug resistance, and cell surface P-glycoprotein in DNA-mediated transformants of mouse cells.
    Robertson SM; Ling V; Stanners CP
    Mol Cell Biol; 1984 Mar; 4(3):500-6. PubMed ID: 6144041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chromosome-mediated gene transfer of multidrug resistance.
    Gros P; Fallows DA; Croop JM; Housman DE
    Mol Cell Biol; 1986 Nov; 6(11):3785-90. PubMed ID: 3796594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metaphase chromosome anomaly: association with drug resistance and cell-specific products.
    Biedler JL; Spengler BA
    Science; 1976 Jan; 191(4223):185-7. PubMed ID: 942798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered glycosidase levels in drug-resistant mouse leukemias.
    Bosmann HB; Kessel D
    Mol Pharmacol; 1970 Jul; 6(4):345-9. PubMed ID: 5464247
    [No Abstract]   [Full Text] [Related]  

  • 65. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.
    Juliano RL; Ling V
    Biochim Biophys Acta; 1976 Nov; 455(1):152-62. PubMed ID: 990323
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin.
    Garman D; Albers L; Center MS
    Biochem Pharmacol; 1983 Dec; 32(23):3633-7. PubMed ID: 6651880
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ganglioside composition of malignant and actinomycin D-resistant nonmalignant Chinese hamster cells.
    Peterson RH; Beutler WJ; Biedler JL
    Biochem Pharmacol; 1979 Mar; 28(5):579-82. PubMed ID: 444244
    [No Abstract]   [Full Text] [Related]  

  • 68. Increased synthesis of a low molecular weight protein in vincristine-resistant cells.
    Meyers MB; Biedler JL
    Biochem Biophys Res Commun; 1981 Mar; 99(1):228-35. PubMed ID: 7236262
    [No Abstract]   [Full Text] [Related]  

  • 69. DNA-mediated transfer of actinomycin D resistance into cultured mouse cells.
    Suárez HG; Nardeux PC; Barbich M
    Exp Cell Res; 1985 Feb; 156(2):553-7. PubMed ID: 3967692
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro phosphorylation and the identification of multiple protein changes in membranes of Chinese hamster lung cells resistant to adriamycin.
    Marsh W; Center MS
    Biochem Pharmacol; 1985 Dec; 34(23):4180-4. PubMed ID: 4062988
    [No Abstract]   [Full Text] [Related]  

  • 71. Tumour cell resistance to anthracyclines--a review.
    Kaye S; Merry S
    Cancer Chemother Pharmacol; 1985; 14(2):96-103. PubMed ID: 2982511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Decreased accumulation of fluorescent dyes in cells with multiple drug resistance].
    Neĭfakh AA; Aleksandrova AIu
    Dokl Akad Nauk SSSR; 1986; 291(4):989-91. PubMed ID: 3803185
    [No Abstract]   [Full Text] [Related]  

  • 73. Frequency of double minute chromosomes and combined cytogenetic abnormalities and their characteristics.
    Fan Y; Mao R; Lv H; Xu J; Yan L; Liu Y; Shi M; Ji G; Yu Y; Bai J; Jin Y; Fu S
    J Appl Genet; 2011 Feb; 52(1):53-9. PubMed ID: 21107781
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker.
    Sridhar KS; Krishan A; Samy TS; Duncan RC; Sauerteig A; McPhee GV; Auguste ME; Benedetto PW
    Cancer Chemother Pharmacol; 1994; 34(5):377-84. PubMed ID: 8070004
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results. The Kyushu University Urological Oncology Group.
    Naito S; Ueda T; Kotoh S; Iguchi A; Sagiyama K; Hiratsuka Y; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S76-80. PubMed ID: 7994792
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reverse transformation of multidrug-resistant cells.
    Biedler JL; Spengler BA
    Cancer Metastasis Rev; 1994 Jun; 13(2):191-207. PubMed ID: 7923550
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multidrug resistance.
    Ling V; Gerlach J; Kartner N
    Breast Cancer Res Treat; 1984; 4(2):89-94. PubMed ID: 6146362
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells.
    Meyers MB; Spengler BA; Chang TD; Melera PW; Biedler JL
    J Cell Biol; 1985 Feb; 100(2):588-97. PubMed ID: 3968181
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.
    Fojo AT; Whang-Peng J; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7661-5. PubMed ID: 3865187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vivo characterization of a doxorubicin resistant B16 melanoma cell line.
    Formelli F; Rossi C; Supino R; Parmiani G
    Br J Cancer; 1986 Aug; 54(2):223-33. PubMed ID: 3741758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.